{"hands_on_practices": [{"introduction": "A cornerstone of managing cardiomyopathies is the objective quantification of cardiac function. This practice applies fundamental definitions to calculate stroke volume and ejection fraction, two critical measures of systolic performance. By analyzing echocardiographic data before and after therapy in a patient with dilated cardiomyopathy, you will gain hands-on experience in assessing therapeutic efficacy and understanding the clinical impact of guideline-directed medical treatment [@problem_id:4808840].", "problem": "A 58-year-old person with symptomatic dilated cardiomyopathy (DCM) undergoes transthoracic echocardiography before and after initiation of guideline-directed medical therapy that includes a beta-adrenergic receptor antagonist, a renin-angiotensin-aldosterone system inhibitor, and a sodium-glucose cotransporter-2 inhibitor. At baseline, the end-diastolic volume (EDV) is measured as $220\\,\\mathrm{mL}$ and the end-systolic volume (ESV) as $170\\,\\mathrm{mL}$. After $6$ months of therapy, the EDV is $200\\,\\mathrm{mL}$ and the ESV is $120\\,\\mathrm{mL}$. Using the standard definitions of stroke volume and ejection fraction, compute the baseline and post-therapy values, and then determine the absolute change in ejection fraction, defined as $I = EF_{\\text{post}} - EF_{\\text{pre}}$. Report $I$ as a unitless decimal fraction. Round your final result to four significant figures. Do not use a percentage sign.", "solution": "The problem presents a clinical scenario involving a patient with dilated cardiomyopathy and asks for the calculation of the change in cardiac ejection fraction following a course of medical therapy. The problem is scientifically grounded, well-posed, and contains all necessary quantitative data for a unique solution.\n\nFirst, we must define the primary physiological parameters involved. Stroke Volume, denoted as $SV$, is the volume of blood pumped from a ventricle of the heart during one contraction. It is calculated as the difference between the end-diastolic volume ($EDV$) and the end-systolic volume ($ESV$):\n$$SV = EDV - ESV$$\nEjection Fraction, denoted as $EF$, is the volumetric fraction of blood pumped out of the ventricle with each heartbeat. It is a critical measure of cardiac systolic function. It is defined as the ratio of the stroke volume to the end-diastolic volume:\n$$EF = \\frac{SV}{EDV} = \\frac{EDV - ESV}{EDV}$$\nThe problem provides data at two time points: baseline (pre-therapy) and after $6$ months of treatment (post-therapy). Let us denote these with the subscripts 'pre' and 'post', respectively.\n\nThe given values are:\n- Baseline (pre-therapy):\n  - End-diastolic volume, $EDV_{\\text{pre}} = 220\\,\\mathrm{mL}$\n  - End-systolic volume, $ESV_{\\text{pre}} = 170\\,\\mathrm{mL}$\n- Post-therapy:\n  - End-diastolic volume, $EDV_{\\text{post}} = 200\\,\\mathrm{mL}$\n  - End-systolic volume, $ESV_{\\text{post}} = 120\\,\\mathrm{mL}$\n\nOur first step is to calculate the baseline ejection fraction, $EF_{\\text{pre}}$.\nUsing the baseline volumes:\n$$EF_{\\text{pre}} = \\frac{EDV_{\\text{pre}} - ESV_{\\text{pre}}}{EDV_{\\text{pre}}} = \\frac{220 - 170}{220} = \\frac{50}{220}$$\nSimplifying the fraction gives:\n$$EF_{\\text{pre}} = \\frac{5}{22}$$\n\nNext, we calculate the post-therapy ejection fraction, $EF_{\\text{post}}$.\nUsing the post-therapy volumes:\n$$EF_{\\text{post}} = \\frac{EDV_{\\text{post}} - ESV_{\\text{post}}}{EDV_{\\text{post}}} = \\frac{200 - 120}{200} = \\frac{80}{200}$$\nSimplifying this fraction gives:\n$$EF_{\\text{post}} = \\frac{8}{20} = \\frac{2}{5}$$\n\nThe problem requires the computation of the absolute change in ejection fraction, defined as $I = EF_{\\text{post}} - EF_{\\text{pre}}$. Substituting the calculated fractions:\n$$I = \\frac{2}{5} - \\frac{5}{22}$$\nTo subtract these fractions, we find a common denominator, which is $5 \\times 22 = 110$.\n$$I = \\frac{2 \\times 22}{5 \\times 22} - \\frac{5 \\times 5}{22 \\times 5} = \\frac{44}{110} - \\frac{25}{110}$$\n$$I = \\frac{44 - 25}{110} = \\frac{19}{110}$$\nThe problem asks for this result as a unitless decimal fraction rounded to four significant figures. We convert the exact fraction to a decimal:\n$$I = \\frac{19}{110} \\approx 0.17272727...$$\nTo round this to four significant figures, we identify the first four non-zero digits, which are $1$, $7$, $2$, and $7$. The fifth significant digit is $2$. Since $2$ is less than $5$, we do not round up the fourth significant digit.\nTherefore, the rounded value is:\n$$I \\approx 0.1727$$\nThis represents the absolute improvement in the patient's ejection fraction as a result of the medical therapy.", "answer": "$$\\boxed{0.1727}$$", "id": "4808840"}, {"introduction": "Beyond simple functional metrics, a deeper understanding of cardiomyopathy requires grasping the underlying biomechanics. This exercise utilizes the Law of Laplace to model how geometric changes in the left ventricle—specifically the dilation and wall thinning seen in dilated cardiomyopathy—directly impact myocardial wall stress. By calculating this change, you will explore a key pathophysiological principle that drives the vicious cycle of adverse remodeling and increased myocardial oxygen demand [@problem_id:4808850].", "problem": "A patient with newly diagnosed dilated cardiomyopathy presents with progressive dyspnea. At the same instant of the cardiac cycle in two serial evaluations (before and after remodeling), left ventricular geometry can be approximated as a thin-walled sphere with uniform wall stress. Let the transmural pressure be constant and equal to $P$, the initial radius be $r_{0}$, and the initial wall thickness be $h_{0}$. After remodeling, the radius increases by $0.20$ relative to baseline (so the new radius is $r_{1} = 1.20\\,r_{0}$), and the wall thickness decreases by $0.10$ relative to baseline (so the new thickness is $h_{1} = 0.90\\,h_{0}$). \n\nStarting from the fundamental force balance on a thin-walled spherical shell, derive the relation between wall stress, pressure, radius, and wall thickness, and then compute the factor by which the wall stress changes due to the remodeling (that is, compute $\\sigma_{1}/\\sigma_{0}$). Briefly interpret the hemodynamic consequence of this change in wall stress in the context of dilated versus hypertrophic cardiomyopathy, focusing on myocardial afterload and oxygen demand.\n\nExpress the final change factor $\\sigma_{1}/\\sigma_{0}$ as a simplified fraction without units. No rounding is required.", "solution": "The left ventricle can be idealized as a thin-walled spherical shell with uniform wall stress. To obtain the relationship between wall stress and geometry, consider a hemispherical section of the sphere cut by a plane through its center. The internal pressure $P$ exerts a net force on this hemisphere equal to the pressure times the projected area of the hemisphere. The projected area is a circle of radius $r$, so the net pressure force is\n$$\nF_{P} = P \\cdot \\pi r^{2}.\n$$\nThis force must be balanced by the tensile (circumferential) force developed in the wall along the cut edge. If the wall has thickness $h$ and circumferential stress $\\sigma$ (force per unit area), the total tensile force around the circumference is the product of stress, thickness, and the length of the circumference, which is $2\\pi r$:\n$$\nF_{\\text{tension}} = \\sigma \\cdot h \\cdot 2\\pi r.\n$$\nAt static equilibrium for the hemispherical section,\n$$\nF_{\\text{tension}} = F_{P} \\quad \\Rightarrow \\quad \\sigma \\cdot h \\cdot 2\\pi r = P \\cdot \\pi r^{2}.\n$$\nSolving for $\\sigma$ yields the thin-walled spherical Laplace relationship:\n$$\n\\sigma = \\frac{P r}{2 h}.\n$$\nLet the initial geometry be $(r_{0}, h_{0})$ and the remodeled geometry be $(r_{1}, h_{1})$. The corresponding wall stresses are\n$$\n\\sigma_{0} = \\frac{P r_{0}}{2 h_{0}}, \\qquad \\sigma_{1} = \\frac{P r_{1}}{2 h_{1}}.\n$$\nThe change factor in wall stress is\n$$\n\\frac{\\sigma_{1}}{\\sigma_{0}} = \\frac{\\frac{P r_{1}}{2 h_{1}}}{\\frac{P r_{0}}{2 h_{0}}} = \\frac{r_{1}/h_{1}}{r_{0}/h_{0}}.\n$$\nGiven $r_{1} = 1.20\\,r_{0}$ and $h_{1} = 0.90\\,h_{0}$, we have\n$$\n\\frac{\\sigma_{1}}{\\sigma_{0}} = \\frac{1.20\\,r_{0}/(0.90\\,h_{0})}{r_{0}/h_{0}} = \\frac{1.20}{0.90} = \\frac{12}{9} = \\frac{4}{3}.\n$$\nThus, wall stress increases by a factor of $\\frac{4}{3}$ relative to baseline.\n\nInterpretation for internal medicine: In dilated cardiomyopathy, chamber radius $r$ tends to increase and wall thickness $h$ may decrease due to eccentric remodeling, which, via the Laplace relationship $\\sigma \\propto r/h$, elevates wall stress. Increased wall stress constitutes higher myocardial afterload and raises myocardial oxygen demand, promoting adverse neurohormonal activation and further remodeling, thereby risking a vicious cycle of progressive dilation and systolic dysfunction. In contrast, hypertrophic cardiomyopathy typically features increased wall thickness $h$ (often with normal or reduced $r$), which tends to reduce wall stress by this relationship, although overall hemodynamics are dominated by diastolic dysfunction and outflow tract obstruction. Restrictive cardiomyopathy often has relatively normal wall thickness and radius but severe diastolic stiffness; wall stress may not be markedly elevated by geometry alone, yet filling pressures and symptoms are driven by impaired compliance. In the present scenario, the computed factor $\\frac{4}{3}$ indicates a substantial increase in wall stress, consistent with the pathophysiology of dilated cardiomyopathy and its implication of increased afterload and oxygen demand.", "answer": "$$\\boxed{\\frac{4}{3}}$$", "id": "4808850"}, {"introduction": "While systolic function is key in dilated cardiomyopathy, diastolic dysfunction is the hallmark of hypertrophic and restrictive cardiomyopathies. This advanced problem challenges you to use the $E/e'$ ratio, a common noninvasive tool for estimating cardiac filling pressures, and to critically analyze its limitations in specific disease states. This practice emphasizes that expert clinical reasoning involves not just applying formulas, but understanding when and why their underlying assumptions may fail in complex pathologies like hypertrophic cardiomyopathy and cardiac amyloidosis [@problem_id:4808904].", "problem": "A clinician evaluates two patients with suspected cardiomyopathy using transthoracic echocardiography with pulsed-wave Doppler of mitral inflow and tissue Doppler imaging of the mitral annulus. The goal is to estimate left ventricular filling pressures by interpreting the ratio of early mitral inflow velocity to early diastolic annular velocity, denoted $E/e'$, and to reason from first principles why the method may fail in specific phenotypes. Use the following fundamental base: transmitral early diastolic inflow velocity $E$ primarily reflects the instantaneous left atrium–left ventricle pressure gradient during early filling; the early diastolic annular velocity $e'$ reflects the rate of myocardial relaxation and restoring forces of the longitudinal left ventricular wall. In general, higher left atrial pressure increases $E$, whereas impaired relaxation decreases $e'$. The $E/e'$ ratio is used as a noninvasive surrogate of mean left atrial pressure, with the implicit assumption that $e'$ adequately captures the relaxation component so that the ratio tracks preload. Avoid assuming that this calibration is phenotype invariant.\n\nAssume sinus rhythm, stable heart rate without post-extrasystolic beats, no more than trivial mitral regurgitation, and proper Doppler alignment. In the absence of conduction delay, use the average of septal and lateral $e'$ when asked to compute $E/e'$.\n\nPatient $1$ (hypertrophic cardiomyopathy): Asymmetric septal hypertrophy is present on imaging. Mitral inflow shows an early diastolic $E$ velocity of $0.60\\,\\text{m/s}$ (that is, $60\\,\\text{cm/s}$). Tissue Doppler at the mitral annulus measures septal $e' = 4\\,\\text{cm/s}$ and lateral $e' = 9\\,\\text{cm/s}$.\n\nPatient $2$ (cardiac amyloidosis): A thick-walled, biatrial enlarged heart with granular sparkling is noted. Mitral inflow shows $E = 1.20\\,\\text{m/s}$ (that is, $120\\,\\text{cm/s}$). Tissue Doppler measures septal $e' = 3\\,\\text{cm/s}$ and lateral $e' = 4\\,\\text{cm/s}$. After aggressive decongestion the invasive pulmonary capillary wedge pressure is measured at $12\\,\\text{mmHg}$, yet the echocardiographic velocities are unchanged.\n\nTasks:\n$1.$ Compute the averaged-annulus $E/e'$ for each patient from the provided velocities, showing the intermediate step of calculating the averaged $e'$.\n$2.$ Using only the fundamental base above and the computed ratios, reason whether $E/e'$ is likely to faithfully reflect mean left atrial pressure in each phenotype, and why the underlying assumptions may break down.\n$3.$ Select the option(s) that best align with the calculations and a first-principles understanding of $E$, $e'$, and their limitations in hypertrophic cardiomyopathy and cardiac amyloidosis.\n\nOptions:\nA. For Patient $1$, the averaged $E/e'$ computed from the given data is approximately $9$, which may under-represent true filling pressures because regional heterogeneity (basal septal $e'$ depression with relative lateral preservation) violates the assumption that annular $e'$ uniformly reflects global relaxation; therefore $E/e'$ correlates only modestly with invasive filling pressures in hypertrophic cardiomyopathy.\n\nB. For Patient $1$, the septal annular $E/e'$ of approximately $15$ is preferred over the averaged value and is a robust, phenotype-independent estimator of mean left atrial pressure across cardiomyopathies.\n\nC. For Patient $2$, the averaged $E/e'$ of approximately $34$ necessarily proves markedly elevated filling pressures in this individual, because tissue Doppler $e'$ is load independent even in infiltrative disease, preserving the calibration of $E/e'$.\n\nD. In cardiac amyloidosis (Patient $2$), the markedly reduced annular $e'$ from diffuse infiltration can keep $E/e'$ high even after decongestion and normalization of pulmonary capillary wedge pressure, breaking the calibration between $E/e'$ and true mean left atrial pressure; reliance on $E/e'$ alone risks overestimating filling pressures.\n\nE. In both patients, averaging septal and lateral $e'$ eliminates regional effects and restores the accuracy of $E/e'$ to estimate left ventricular filling pressures to the same degree as in structurally normal hearts.\n\nF. When atrial fibrillation is present, $E/e'$ should be measured on any single beat because cycle-length dependence does not influence transmitral $E$ or annular $e'$, and thus $E/e'$ is unaffected by rhythm irregularity.", "solution": "The problem statement is scientifically grounded, well-posed, objective, and internally consistent, providing sufficient data to perform the required calculations and reasoning. The given physiological principles and patient data are realistic and pertinent to the field of cardiovascular hemodynamics. Proceeding to a solution is warranted.\n\nThe solution involves three tasks as specified:\n$1$. Computation of the averaged-annulus $E/e'$ for each patient.\n$2$. Reasoning based on first principles regarding the validity of the $E/e'$ ratio in the specified phenotypes.\n$3$. Evaluation of the provided options.\n\n**Task 1: Computation of $E/e'$ Ratios**\n\nThe averaged mitral annular early diastolic velocity, denoted $\\overline{e'}$, is the arithmetic mean of the septal and lateral annular velocities. The ratio $E/e'$ is then computed using this averaged value. All velocities must be in consistent units (e.g., $\\text{cm/s}$).\n\n**For Patient 1 (Hypertrophic Cardiomyopathy):**\n- Given transmitral early diastolic inflow velocity, $E = 0.60\\,\\text{m/s} = 60\\,\\text{cm/s}$.\n- Given septal early diastolic annular velocity, $e'_{\\text{septal}} = 4\\,\\text{cm/s}$.\n- Given lateral early diastolic annular velocity, $e'_{\\text{lateral}} = 9\\,\\text{cm/s}$.\n\nFirst, calculate the averaged annular velocity $\\overline{e'}$:\n$$ \\overline{e'} = \\frac{e'_{\\text{septal}} + e'_{\\text{lateral}}}{2} = \\frac{4\\,\\text{cm/s} + 9\\,\\text{cm/s}}{2} = \\frac{13\\,\\text{cm/s}}{2} = 6.5\\,\\text{cm/s} $$\n\nNext, compute the averaged-annulus $E/e'$ ratio:\n$$ E/\\overline{e'} = \\frac{60\\,\\text{cm/s}}{6.5\\,\\text{cm/s}} \\approx 9.23 $$\n\n**For Patient 2 (Cardiac Amyloidosis):**\n- Given transmitral early diastolic inflow velocity, $E = 1.20\\,\\text{m/s} = 120\\,\\text{cm/s}$.\n- Given septal early diastolic annular velocity, $e'_{\\text{septal}} = 3\\,\\text{cm/s}$.\n- Given lateral early diastolic annular velocity, $e'_{\\text{lateral}} = 4\\,\\text{cm/s}$.\n\nFirst, calculate the averaged annular velocity $\\overline{e'}$:\n$$ \\overline{e'} = \\frac{e'_{\\text{septal}} + e'_{\\text{lateral}}}{2} = \\frac{3\\,\\text{cm/s} + 4\\,\\text{cm/s}}{2} = \\frac{7\\,\\text{cm/s}}{2} = 3.5\\,\\text{cm/s} $$\n\nNext, compute the averaged-annulus $E/e'$ ratio:\n$$ E/\\overline{e'} = \\frac{120\\,\\text{cm/s}}{3.5\\,\\text{cm/s}} \\approx 34.29 $$\n\n**Task 2: First-Principles Reasoning on the Validity of $E/e'$**\n\nThe fundamental basis provided is that $E$ reflects the left atrium-left ventricle (LA-LV) pressure gradient, while $e'$ reflects myocardial relaxation. The ratio $E/e'$ is used as a surrogate for mean LA pressure (preload) under the crucial assumption that $e'$ accurately isolates the influence of relaxation, such that the ratio primarily tracks the pressure component.\n\n**Patient 1 (Hypertrophic Cardiomyopathy - HCM):**\nIn HCM, particularly the asymmetric septal variant, the underlying pathology is not uniform. The basal septum is often fibrotic and profoundly hypertrophied, leading to severely depressed motion, hence the very low $e'_{\\text{septal}}$ of $4\\,\\text{cm/s}$. The lateral wall may be less affected, showing a relatively preserved $e'_{\\text{lateral}}$ of $9\\,\\text{cm/s}$. This significant regional heterogeneity challenges the core assumption that a single $e'$ value (even an average) can represent the \"global\" LV relaxation properties that influence filling. The very low septal $e'$ may be a consequence of the localized disease process itself, rather than purely a reflection of relaxation changes due to elevated filling pressure. Averaging a pathologically depressed septal velocity with a more normal lateral velocity creates an ambiguous number ($6.5\\,\\text{cm/s}$) that may not scale correctly with LA pressure. This discrepancy or \"uncoupling\" between regional myocardial mechanics and global diastolic pressures is why $E/e'$ is known to have a weaker correlation with invasive filling pressures in HCM compared to other conditions. The computed ratio of $\\approx 9$ is in an indeterminate range and may under- or overestimate the true pressure depending on which annular site's velocity is more artifactually affected by the regional pathology.\n\n**Patient 2 (Cardiac Amyloidosis):**\nCardiac amyloidosis is a diffuse infiltrative disease. Amyloid fibrils deposit throughout the myocardium, causing extreme stiffness and severely impairing relaxation. This is reflected in the globally and severely depressed $e'$ velocities (septal $e'=3\\,\\text{cm/s}$, lateral $e'=4\\,\\text{cm/s}$). The key insight comes from the post-decongestion data: despite lowering the pulmonary capillary wedge pressure (PCWP, a surrogate for LA pressure) to a normal value of $12\\,\\text{mmHg}$, the echo velocities, including $e'$, remain unchanged. This demonstrates a critical breakdown of the $E/e'$ principle. The $e'$ velocity has become so low due to the intrinsic stiffness of the infiltrated myocardium that it is no longer sensitive to changes in preload (i.e., it is \"load-independent\"). Relaxation is severely impaired irrespective of the filling pressure. Therefore, even with normal LA pressure, the denominator $e'$ remains extremely small, causing the $E/e'$ ratio to be persistently and markedly elevated ($\\approx 34$). In this phenotype, a high $E/e'$ is more a marker of the severity of the infiltrative disease than an accurate reflection of the current filling pressure. Relying on it would lead to a significant overestimation of preload.\n\n**Task 3: Evaluation of Options**\n\n**A. For Patient 1, the averaged $E/e'$ computed from the given data is approximately $9$, which may under-represent true filling pressures because regional heterogeneity (basal septal $e'$ depression with relative lateral preservation) violates the assumption that annular $e'$ uniformly reflects global relaxation; therefore $E/e'$ correlates only modestly with invasive filling pressures in hypertrophic cardiomyopathy.**\n- The calculated $E/\\overline{e'}$ is $\\approx 9.23$, which is consistent with \"approximately $9$\".\n- The reasoning provided is entirely correct. The regional heterogeneity in HCM is the principal reason for the modest correlation between $E/e'$ and invasively measured filling pressures. The low value of $9$ could indeed under-represent a truly elevated pressure, as the relatively preserved lateral $e'$ pulls the average $\\overline{e'}$ up and thus the ratio $E/\\overline{e'}$ down.\n- **Verdict: Correct.**\n\n**B. For Patient 1, the septal annular $E/e'$ of approximately $15$ is preferred over the averaged value and is a robust, phenotype-independent estimator of mean left atrial pressure across cardiomyopathies.**\n- The septal $E/e' = 60 / 4 = 15$. The calculation is correct.\n- The claim that it is a \"robust, phenotype-independent estimator\" is false. The problem explicitly warns against assuming phenotype invariance. As established with Patient $2$, the $E/e'$ calibration fails in cardiac amyloidosis. No single $E/e'$ measurement method is robust across all cardiomyopathy phenotypes.\n- **Verdict: Incorrect.**\n\n**C. For Patient 2, the averaged $E/e'$ of approximately $34$ necessarily proves markedly elevated filling pressures in this individual, because tissue Doppler $e'$ is load independent even in infiltrative disease, preserving the calibration of $E/e'$.**\n- The calculated $E/\\overline{e'}$ is $\\approx 34.29$, consistent with \"approximately $34$\".\n- The conclusion that it \"necessarily proves markedly elevated filling pressures\" is directly contradicted by the problem data, which states the post-decongestion PCWP is $12\\,\\text{mmHg}$.\n- The reasoning is fundamentally flawed. The fact that $e'$ becomes load-*independent* is what *breaks* the calibration, it does not preserve it. The calibration relies on $e'$ dynamically reflecting relaxation properties as they are influenced by preload.\n- **Verdict: Incorrect.**\n\n**D. In cardiac amyloidosis (Patient 2), the markedly reduced annular $e'$ from diffuse infiltration can keep $E/e'$ high even after decongestion and normalization of pulmonary capillary wedge pressure, breaking the calibration between $E/e'$ and true mean left atrial pressure; reliance on $E/e'$ alone risks overestimating filling pressures.**\n- This statement accurately describes the pathophysiology and the limitation of the technique in cardiac amyloidosis, as detailed in the first-principles analysis for Patient $2$. The infiltration causes a fixed, low $e'$ that is uncoupled from loading conditions. This leads to a persistently high $E/e'$ ratio even when LA pressure is normal, resulting in overestimation of filling pressures.\n- **Verdict: Correct.**\n\n**E. In both patients, averaging septal and lateral $e'$ eliminates regional effects and restores the accuracy of $E/e'$ to estimate left ventricular filling pressures to the same degree as in structurally normal hearts.**\n- This claim is false. Averaging does not \"eliminate\" regional effects in HCM; it mathematically combines them into a potentially misleading value. It certainly does not \"restore accuracy\". In both HCM and amyloidosis, the underlying pathology fundamentally alters the relationship between $e'$ and loading, a problem that simple averaging cannot solve. The accuracy is demonstrably inferior to that in structurally normal hearts.\n- **Verdict: Incorrect.**\n\n**F. When atrial fibrillation is present, $E/e'$ should be measured on any single beat because cycle-length dependence does not influence transmitral $E$ or annular $e'$, and thus $E/e'$ is unaffected by rhythm irregularity.**\n- This statement is physiologically incorrect. The patients are in sinus rhythm, but the claim itself is flawed. In atrial fibrillation, the cardiac cycle length varies from beat to beat. Both the transmitral flow velocity $E$ (dependent on filling time) and the annular velocity $e'$ are known to be highly dependent on the preceding cycle length. To obtain a representative measure, values from multiple beats (typically $5$ to $10$) must be averaged. Measuring a single beat would be unreliable.\n- **Verdict: Incorrect.**", "answer": "$$\\boxed{AD}$$", "id": "4808904"}]}